Prodesse
About:
Prodesse develops molecular diagnostic reagents for a variety of infectious disease applications.
Website: http://www.prodesse.com
Top Investors: Wisconsin Investment Partners, Silicon Pastures, Jeff Rusinow, Andrew Shannon, Thomas Shannon
Description:
Prodesse develops molecular diagnostic reagents for a variety of infectious disease applications. Prodesse sells three FDA 510(k) cleared products in the United States, and two additional CE-marked products in Europe. The company's products can be used in conjunction with various nucleic acid extraction and real-time PCR (polymerase chain reaction) platforms, including Cepheid's SmartCycler(®) II System.
$1.5M
Milwaukee, Wisconsin, United States
1993-01-01
Kelly Henrickson, Thomas Shannon
1-10
2002-01-01
Private
© 2025 bioDAO.ai